Purpose 2 Study

A Gilead study is going to study the efficacy and safety of injectable PrEP twice yearly for adults. Transgender women, transgender men and gender nonbinary people over 18 years of age who have sex with partners assigned male at birth may be eligible. Eligible participants will be compensated for $50 for the screening visit, which includes a free rapid HIV test and up to $2,275 for their time in the study.

For more information, please call or text 617.927.6450 or email bethechange@fenwayhealth.org

You can also fill out the eligibility survey and be contacted after – https://fenwaychrc.iad1.qualtrics.com/jfe/form/SV_eIDpM715IRLmaVg

 

Translate »
X